Kaushiki

Stock market set to plateau after euphoria of last four years: Zerodha’s Nithin Kamath

Stock market set to plateau after euphoria of last four years: Zerodha’s Nithin Kamath

Nithin Kamath, chief executive officer of Zerodha, stated that the development possibilities for the Bengaluru-based company in the upcoming years will be impacted by the stock market’s expected plateau following the exuberance of the previous four years, which resulted in record participation from individual investors. “Zerodha’s performance would be highly correlated with the performance of […]

Stock market set to plateau after euphoria of last four years: Zerodha’s Nithin Kamath Read More »

Asian stocks weaken as Fed policy doubts simmer: Know More Here

Asian stocks weaken as Fed policy doubts simmer: Know More Here

Early on Monday, Asian equities fell as traders tempered their expectations of interest rate reduction from the Federal Reserve in response to further evidence of the US economy’s resiliency. Australian and Japanese stocks dropped. Samsung Electronics Co.’s surge on the announcement of its stock repurchase plan was the catalyst for South Korea’s benchmark to defy

Asian stocks weaken as Fed policy doubts simmer: Know More Here Read More »

Asian Stocks Gain on China Recovery, Weaker Dollar: Markets Wrap

Asian Stocks Gain on China Recovery, Weaker Dollar: Markets Wrap

A decline in the dollar and indications of economic stabilization in China helped Asian stocks rise. Australia’s and Hong Kong’s stocks rose after statistics revealed that China’s retail sales growth was the largest in eight months. Because of the yen’s depreciation, Japanese benchmarks increased by almost 0.8%. US contracts declined. A five-day increase that was

Asian Stocks Gain on China Recovery, Weaker Dollar: Markets Wrap Read More »

Q2 Results Review: 66% companies see EPS cut, small and midcaps hit hard

Q2 Results Review: 66% companies see EPS cut, small and midcaps hit hard

Muted sales growth and a drop in profits and margins have been the hallmarks of the second quarter of FY25’s disappointing corporate earnings. Notwithstanding the respectable performance of the Banking, Financial Services, and Insurance (BFSI) industry, non-financial businesses nonetheless confront formidable obstacles. 45% of the 227 companies in the 275-stock JM Financial coverage area have

Q2 Results Review: 66% companies see EPS cut, small and midcaps hit hard Read More »

Japan's Nikkei rises as auto, bank shares gain: All You Need To Know

Japan’s Nikkei rises as auto, bank shares gain: All You Need To Know

As a weaker yen helped manufacturers and financial sectors rise after increasing their yearly profit projections, Japan’s Nikkei share average increased on Friday. The Nikkei is expected to lose 2.4% for the week, despite being up 0.8% at 38,842.13 during the lunch break. Although the overall Topix has increased by 0.86% to 2,724.35, it is

Japan’s Nikkei rises as auto, bank shares gain: All You Need To Know Read More »

JB Pharma, Sun, Torrent ,Lupin, Abbott lead pharma market growth : Know More Here

JB Pharma, Sun, Torrent ,Lupin, Abbott lead pharma market growth : Know More Here

In November, the Nifty Pharma index had a 4% drop. Even though it started on a high base, the growth of the Indian pharmaceutical industry in October was not particularly encouraging, and the selling pressure in the domestic markets is what caused this fall. According to reports, the growth of the pharmaceutical market in October

JB Pharma, Sun, Torrent ,Lupin, Abbott lead pharma market growth : Know More Here Read More »

Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs

Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs

Bharat Serums and Vaccines Limited (BSV), a fully-owned subsidiary of Mankind Pharma Limited, has pledged 39.68 per cent of its equity stake to secure non-convertible debentures (NCDs) worth ₹5,000 crores. As the common security trustee for these NCDs, Catalyst Trusteeship Limited was designated by SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015. The share price

Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs Read More »

Eicher Motors shares rally 8% after steady Q2 earnings. What analysts say

Eicher Motors shares rally 8% after steady Q2 earnings. What analysts say

In early morning trading on Thursday, November 14, shares of Eicher Motors, the world leader in the middleweight motorbike market, jumped by about 8% to ₹4,940 per share after the firm reported a higher-than-expected quarterly profit on Wednesday. Strong sales of higher-margin motorcycles with engine displacements greater than 350 cc propelled the rhythm. Despite fierce

Eicher Motors shares rally 8% after steady Q2 earnings. What analysts say Read More »